Loading…
Based on limited metadata with the full warning letter text unavailable, Fair Price Labs, Inc. received an FDA warning letter on July 24, 2020 regarding medical devices. Without access to the specific subject line or detailed violation information, the precise nature of the regulatory concerns cannot be determined from this metadata alone. The warning was issued under FDA's medical device regulatory authority, though the specific issuing office and violation count are not documented in the available information. To understand the company's specific compliance failures and required corrective actions, the complete warning letter text would need to be reviewed.